During the past decade, UVA Health System Division of Hematology & Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "UVA Health System Division of Hematology & Oncology" #1 collaborator was "ICON Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "UVA Health System Division of Hematology & Oncology" are "Myelodysplastic Syndromes" (2 trials), "B-cell Non-Hodgkins Lymphoma" (1 trials), "Breast Cancer" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "UVA Health System Division of Hematology & Oncology" in a lesser frequency.

Most popular intervention types in "UVA Health System Division of Hematology & Oncology" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azacitidine" (2 trials), "5-Fluorouracil" (1 trials), "Atezolizumab" (1 trials), "Cyclophosphamide" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "UVA Health System Division of Hematology & Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "UVA Health System Division of Hematology & Oncology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UVA Health System Division of Hematology & Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UVA Health System Division of Hematology & Oncology, 2 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".